Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts.

Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts.

来源:Barrons发布于 2026-11-06

Moderna posts higher-than-expected revenue as results get a lift from international Covid vaccine demand.

相关标的:MRNA

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。